Company Filing History:
Years Active: 2013
Title: Victoria Jane Philbin: Innovator in TLR3 Agonist Compounds
Introduction
Victoria Jane Philbin is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of toll-like receptor 3 (TLR3) agonist compounds. Her innovative work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Victoria holds a patent for "Agonists of toll-like receptor 3 and methods of their use." This patent includes TLR3 agonist compounds, compositions, and methods designed to stimulate TLR3 activity. The compositions consist of oligonucleotide-based compounds that bind to and activate TLR3. Additionally, these compositions may include other therapeutic and prophylactic compounds to enhance their effectiveness. The methods outlined in her patent provide a framework for using these compounds in the prevention or treatment of diseases where modulation of TLR3 activity is beneficial.
Career Highlights
Victoria is currently associated with Idera Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work at Idera Pharmaceuticals focuses on innovative solutions that leverage her expertise in TLR3 agonists.
Collaborations
Victoria has collaborated with notable colleagues, including Ekambar R Kandimalla and Tao Lan. These partnerships have contributed to the advancement of her research and the development of new therapeutic approaches.
Conclusion
Victoria Jane Philbin is a trailblazer in the field of biotechnology, with her patent on TLR3 agonist compounds showcasing her innovative spirit. Her contributions have the potential to lead to significant advancements in medical treatments.